4th Quarter - Amendment
MS. TAMI WAHL for ROCK & ASSOCIATES
Firm
Client
Income
$10,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Appropriations to fund the implementation of regulations impacting pharmacy compounding.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES ROCK | — |
| TAMI WAHL | — |
Health Issues HCR
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES ROCK | — |
| TAMI WAHL | — |
Pharmacy PHA
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES ROCK | — |
| TAMI WAHL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.